Free Trial
→ A New Way to Double Your Retirement Income? (From Investors Alley) (Ad)tc pixel Free CSLLY Stock Alerts

CSL (CSLLY) Stock Forecast & Price Target

CSL logo
$67.61 -0.81 (-1.18%)
As of 03:59 PM Eastern
Compare

CSL - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Strong Buy
Based on 1 Analyst Ratings
Sell
0
Hold
0
Buy
1

Based on 1 Wall Street analysts who have issued ratings for CSL in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 1 analysts, 1 has given a strong buy rating for CSLLY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CSLLY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CSL and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CSLLY Analyst Ratings Over Time

TypeCurrent Forecast
9/15/24 to 9/15/25		1 Month Ago
8/16/24 to 8/16/25		3 Months Ago
6/17/24 to 6/17/25		1 Year Ago
9/16/23 to 9/15/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
2 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingStrong BuyStrong BuyStrong BuyStrong Buy

CSLLY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CSLLY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CSL Stock vs. The Competition

TypeCSLMedical CompaniesS&P 500
Consensus Rating Score
4.00
2.79
2.53
Consensus RatingStrong BuyModerate BuyModerate Buy
Predicted UpsideN/A17,514.66% Upside10.58% Upside
News Sentiment Rating
Positive News

See Recent CSLLY News
Positive News
Positive News
Export to Excel
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
1/16/2025The Goldman Sachs Group
3 of 5 stars
D. Thillainathan
Not Rated
UpgradeStrong-Buy
8/13/2024Macquarie
2 of 5 stars
D. Bailey
Not Rated
UpgradeStrong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 06:55 PM ET.


Should I Buy CSL Stock? CSLLY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, September 10, 2025. Please send any questions or comments about these CSL pros and cons to contact@marketbeat.com.

CSL
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in CSL Limited:

  • The current stock price is around $72, reflecting a recent increase of approximately 1.9%, which may indicate positive market sentiment.
  • CSL Limited has experienced significant growth in short interest, suggesting that investors are increasingly confident in the company's future performance.
  • The company operates in multiple segments, including CSL Behring, CSL Seqirus, and CSL Vifor, diversifying its revenue streams and reducing risk.
  • CSL Limited is involved in the development and distribution of biopharmaceuticals and vaccines, sectors that are critical and growing, especially in the context of global health needs.
  • With a solid debt-to-equity ratio of 0.45, CSL Limited demonstrates a strong balance sheet, indicating financial stability and lower risk for investors.

CSL
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in CSL Limited for these reasons:

  • The stock has a 50-day moving average of $82.40, which is higher than the current price, potentially indicating a downward trend.
  • CSL Limited's one-year high of $109.00 suggests that the stock may be facing resistance at higher price levels, which could limit short-term gains.
  • With a quick ratio of 0.85, the company may face challenges in meeting its short-term liabilities, which could raise concerns for investors.
  • The recent increase in short interest, while indicating confidence, could also suggest that some investors are betting against the stock, which may lead to volatility.
  • As the company operates in highly regulated industries, any changes in regulations or market conditions could adversely affect its operations and profitability.

CSLLY Forecast - Frequently Asked Questions

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CSL in the last year. There is currently 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "strong buy" CSLLY shares.

According to analysts, CSL's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like CSL more than other "medical" companies. The consensus rating for CSL is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CSLLY compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (OTCMKTS:CSLLY) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...
Stansberry Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...
Banyan Hill Publishing | Sponsoredtc pixel
Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...
Brownstone Research | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...
Investors Alley | Sponsoredtc pixel
Strange crypto pattern discovered by 40-person research team
Something unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...
Crypto Swap Profits | Sponsoredtc pixel